Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits
Ischaemic preconditioning protects myocardium from infarction if the reperfusion interval between the brief and prolonged ischaemic intervals is less than 1 h. In anaesthetised rabbits acadesine (5-amino-4-imidazolecarboxamide riboside, AICAR), an adenosine enhancer which increases tissue adenosine...
Gespeichert in:
Veröffentlicht in: | Cardiovascular research 1995-05, Vol.29 (5), p.653-657 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 657 |
---|---|
container_issue | 5 |
container_start_page | 653 |
container_title | Cardiovascular research |
container_volume | 29 |
creator | BURCKHARTT, B XI-MING YANG TSUCHIDA, A MULLANE, K. M DOWNEY, J. M COHEN, M. V |
description | Ischaemic preconditioning protects myocardium from infarction if the reperfusion interval between the brief and prolonged ischaemic intervals is less than 1 h. In anaesthetised rabbits acadesine (5-amino-4-imidazolecarboxamide riboside, AICAR), an adenosine enhancer which increases tissue adenosine during ischaemia, prolongs the window of protection to 2 h. The aim of this study was to try to determine the maximum extension of this window of protection, using chronically instrumented, unsedated rabbits.
Rabbits were instrumented with a balloon occluder around a major branch of the left coronary artery for reversible coronary occlusion. Five to seven days after surgery all animals underwent a 30 min coronary occlusion. Animals were randomised to one of seven groups: (1) No additional treatment (control); (2) Ischaemic preconditioning with 5 min regional ischaemia followed by 10 min reperfusion before the 30 min coronary occlusion; (3) and (4) Ischaemic preconditioning followed by 2 or 4 h of reperfusion before the 30 min occlusion, respectively; (5) Treatment with acadesine (2.5 mg.kg-1.min-1 intravenously for 5 min and then 0.5 mg.kg-1.min-1 beginning 45 min before and continuing until 30 min after release of the 30 min occlusion) without ischaemic preconditioning; (6) and (7) Treatment with the higher dose of acadesine for 5 min beginning 35 min before the 5 min ischaemic period, and then the lower dose continuing until 30 min after release of the 30 min coronary occlusion in rabbits with 4 or 6 h reperfusion intervals, respectively.
Rabbits with ischaemic preconditioning with 10 min reperfusion preceding the 30 min coronary occlusion (group 2) had only 5.6(SEM 1.1)% infarction of the ischaemic zone. Ischaemic preconditioning followed by 2 h reperfusion (group 3) offered continued protection [18.2(2.2)% infarction] as compared to control animals [37.7(2.6)% infarction]. However, protection waned if ischaemic preconditioning was followed by 4 h reperfusion (group 4) [36.7(3.0)% infarction]. Additionally, treatment with acadesine alone did not modify infarct size (group 7) [39.5(4.0)%], but acadesine largely restored the protection of ischaemic preconditioning despite a 4 h reperfusion interval (group 5) [20.4(3.0)% infarction, P < 0.01 v control]. However, when reperfusion was extended to 6 h (group 6) acadesine could no longer restore protection [36.2(0.9)% infarction].
The protection afforded by a 5 min ischaemic preconditioning period lasts from 2 to 4 |
doi_str_mv | 10.1016/0008-6363(96)88636-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77382984</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77382984</sourcerecordid><originalsourceid>FETCH-LOGICAL-c246t-98cf559558b6d27de84473725f55c3307c006c5117d970dfd9fb7d77fd49776b3</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRS0EKqXwByB5gRAsAk78mGRZIV5SJTawthx7DEatA3Eq6N_jQNXV-M6cGV1fQk5Ldl2yUt0wxupCccUvG3VV1_lVqD0yLUHKgldC7pPpDjkkRyl9ZCkliAmZgGIKJJ8SnFvjMIWIFH8GjC7R4R3pd4iu-6adp599N6AdQhep8b7rHTrabmhI9t3gKtgMoO2iCyMS4hsNkWadbOjWifambcOQjsmBN8uEJ9s6I6_3dy-3j8Xi-eHpdr4obCXUUDS19VI2UtatchU4rIUADpXMXcs5A8uYsrIswTXAnHeNb8EBeCcaANXyGbn4v5tdf60xDXqVjeJyaSJmOxqA11VTiwyKf9D2XUo9ev3Zh5XpN7pkekxXj9HpMTrdKP2XblYzcra9v25X6HZL2zjz_Hw7N8mape9NtCHtMC7z74TgvwuJgxc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77382984</pqid></control><display><type>article</type><title>Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits</title><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>BURCKHARTT, B ; XI-MING YANG ; TSUCHIDA, A ; MULLANE, K. M ; DOWNEY, J. M ; COHEN, M. V</creator><creatorcontrib>BURCKHARTT, B ; XI-MING YANG ; TSUCHIDA, A ; MULLANE, K. M ; DOWNEY, J. M ; COHEN, M. V</creatorcontrib><description>Ischaemic preconditioning protects myocardium from infarction if the reperfusion interval between the brief and prolonged ischaemic intervals is less than 1 h. In anaesthetised rabbits acadesine (5-amino-4-imidazolecarboxamide riboside, AICAR), an adenosine enhancer which increases tissue adenosine during ischaemia, prolongs the window of protection to 2 h. The aim of this study was to try to determine the maximum extension of this window of protection, using chronically instrumented, unsedated rabbits.
Rabbits were instrumented with a balloon occluder around a major branch of the left coronary artery for reversible coronary occlusion. Five to seven days after surgery all animals underwent a 30 min coronary occlusion. Animals were randomised to one of seven groups: (1) No additional treatment (control); (2) Ischaemic preconditioning with 5 min regional ischaemia followed by 10 min reperfusion before the 30 min coronary occlusion; (3) and (4) Ischaemic preconditioning followed by 2 or 4 h of reperfusion before the 30 min occlusion, respectively; (5) Treatment with acadesine (2.5 mg.kg-1.min-1 intravenously for 5 min and then 0.5 mg.kg-1.min-1 beginning 45 min before and continuing until 30 min after release of the 30 min occlusion) without ischaemic preconditioning; (6) and (7) Treatment with the higher dose of acadesine for 5 min beginning 35 min before the 5 min ischaemic period, and then the lower dose continuing until 30 min after release of the 30 min coronary occlusion in rabbits with 4 or 6 h reperfusion intervals, respectively.
Rabbits with ischaemic preconditioning with 10 min reperfusion preceding the 30 min coronary occlusion (group 2) had only 5.6(SEM 1.1)% infarction of the ischaemic zone. Ischaemic preconditioning followed by 2 h reperfusion (group 3) offered continued protection [18.2(2.2)% infarction] as compared to control animals [37.7(2.6)% infarction]. However, protection waned if ischaemic preconditioning was followed by 4 h reperfusion (group 4) [36.7(3.0)% infarction]. Additionally, treatment with acadesine alone did not modify infarct size (group 7) [39.5(4.0)%], but acadesine largely restored the protection of ischaemic preconditioning despite a 4 h reperfusion interval (group 5) [20.4(3.0)% infarction, P < 0.01 v control]. However, when reperfusion was extended to 6 h (group 6) acadesine could no longer restore protection [36.2(0.9)% infarction].
The protection afforded by a 5 min ischaemic preconditioning period lasts from 2 to 4 h in the awake, unsedated rabbit, and acadesine can extend the duration of this window of protection to at least 4 h but not to 6 h.</description><identifier>ISSN: 0008-6363</identifier><identifier>EISSN: 1755-3245</identifier><identifier>DOI: 10.1016/0008-6363(96)88636-6</identifier><identifier>PMID: 7606753</identifier><identifier>CODEN: CVREAU</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adenosine - metabolism ; Aminoimidazole Carboxamide - analogs & derivatives ; Aminoimidazole Carboxamide - therapeutic use ; Animals ; Biological and medical sciences ; Cardiovascular system ; Disease Models, Animal ; Medical sciences ; Miscellaneous ; Myocardial Infarction - prevention & control ; Myocardial Ischemia - metabolism ; Myocardial Reperfusion ; Myocardium - metabolism ; Pharmacology. Drug treatments ; Rabbits ; Ribonucleosides - therapeutic use ; Time Factors ; Ventricular Fibrillation - prevention & control</subject><ispartof>Cardiovascular research, 1995-05, Vol.29 (5), p.653-657</ispartof><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c246t-98cf559558b6d27de84473725f55c3307c006c5117d970dfd9fb7d77fd49776b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3555944$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7606753$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BURCKHARTT, B</creatorcontrib><creatorcontrib>XI-MING YANG</creatorcontrib><creatorcontrib>TSUCHIDA, A</creatorcontrib><creatorcontrib>MULLANE, K. M</creatorcontrib><creatorcontrib>DOWNEY, J. M</creatorcontrib><creatorcontrib>COHEN, M. V</creatorcontrib><title>Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits</title><title>Cardiovascular research</title><addtitle>Cardiovasc Res</addtitle><description>Ischaemic preconditioning protects myocardium from infarction if the reperfusion interval between the brief and prolonged ischaemic intervals is less than 1 h. In anaesthetised rabbits acadesine (5-amino-4-imidazolecarboxamide riboside, AICAR), an adenosine enhancer which increases tissue adenosine during ischaemia, prolongs the window of protection to 2 h. The aim of this study was to try to determine the maximum extension of this window of protection, using chronically instrumented, unsedated rabbits.
Rabbits were instrumented with a balloon occluder around a major branch of the left coronary artery for reversible coronary occlusion. Five to seven days after surgery all animals underwent a 30 min coronary occlusion. Animals were randomised to one of seven groups: (1) No additional treatment (control); (2) Ischaemic preconditioning with 5 min regional ischaemia followed by 10 min reperfusion before the 30 min coronary occlusion; (3) and (4) Ischaemic preconditioning followed by 2 or 4 h of reperfusion before the 30 min occlusion, respectively; (5) Treatment with acadesine (2.5 mg.kg-1.min-1 intravenously for 5 min and then 0.5 mg.kg-1.min-1 beginning 45 min before and continuing until 30 min after release of the 30 min occlusion) without ischaemic preconditioning; (6) and (7) Treatment with the higher dose of acadesine for 5 min beginning 35 min before the 5 min ischaemic period, and then the lower dose continuing until 30 min after release of the 30 min coronary occlusion in rabbits with 4 or 6 h reperfusion intervals, respectively.
Rabbits with ischaemic preconditioning with 10 min reperfusion preceding the 30 min coronary occlusion (group 2) had only 5.6(SEM 1.1)% infarction of the ischaemic zone. Ischaemic preconditioning followed by 2 h reperfusion (group 3) offered continued protection [18.2(2.2)% infarction] as compared to control animals [37.7(2.6)% infarction]. However, protection waned if ischaemic preconditioning was followed by 4 h reperfusion (group 4) [36.7(3.0)% infarction]. Additionally, treatment with acadesine alone did not modify infarct size (group 7) [39.5(4.0)%], but acadesine largely restored the protection of ischaemic preconditioning despite a 4 h reperfusion interval (group 5) [20.4(3.0)% infarction, P < 0.01 v control]. However, when reperfusion was extended to 6 h (group 6) acadesine could no longer restore protection [36.2(0.9)% infarction].
The protection afforded by a 5 min ischaemic preconditioning period lasts from 2 to 4 h in the awake, unsedated rabbit, and acadesine can extend the duration of this window of protection to at least 4 h but not to 6 h.</description><subject>Adenosine - metabolism</subject><subject>Aminoimidazole Carboxamide - analogs & derivatives</subject><subject>Aminoimidazole Carboxamide - therapeutic use</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Disease Models, Animal</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Myocardial Infarction - prevention & control</subject><subject>Myocardial Ischemia - metabolism</subject><subject>Myocardial Reperfusion</subject><subject>Myocardium - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Rabbits</subject><subject>Ribonucleosides - therapeutic use</subject><subject>Time Factors</subject><subject>Ventricular Fibrillation - prevention & control</subject><issn>0008-6363</issn><issn>1755-3245</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMtOwzAQRS0EKqXwByB5gRAsAk78mGRZIV5SJTawthx7DEatA3Eq6N_jQNXV-M6cGV1fQk5Ldl2yUt0wxupCccUvG3VV1_lVqD0yLUHKgldC7pPpDjkkRyl9ZCkliAmZgGIKJJ8SnFvjMIWIFH8GjC7R4R3pd4iu-6adp599N6AdQhep8b7rHTrabmhI9t3gKtgMoO2iCyMS4hsNkWadbOjWifambcOQjsmBN8uEJ9s6I6_3dy-3j8Xi-eHpdr4obCXUUDS19VI2UtatchU4rIUADpXMXcs5A8uYsrIswTXAnHeNb8EBeCcaANXyGbn4v5tdf60xDXqVjeJyaSJmOxqA11VTiwyKf9D2XUo9ev3Zh5XpN7pkekxXj9HpMTrdKP2XblYzcra9v25X6HZL2zjz_Hw7N8mape9NtCHtMC7z74TgvwuJgxc</recordid><startdate>199505</startdate><enddate>199505</enddate><creator>BURCKHARTT, B</creator><creator>XI-MING YANG</creator><creator>TSUCHIDA, A</creator><creator>MULLANE, K. M</creator><creator>DOWNEY, J. M</creator><creator>COHEN, M. V</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199505</creationdate><title>Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits</title><author>BURCKHARTT, B ; XI-MING YANG ; TSUCHIDA, A ; MULLANE, K. M ; DOWNEY, J. M ; COHEN, M. V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c246t-98cf559558b6d27de84473725f55c3307c006c5117d970dfd9fb7d77fd49776b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adenosine - metabolism</topic><topic>Aminoimidazole Carboxamide - analogs & derivatives</topic><topic>Aminoimidazole Carboxamide - therapeutic use</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Disease Models, Animal</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Myocardial Infarction - prevention & control</topic><topic>Myocardial Ischemia - metabolism</topic><topic>Myocardial Reperfusion</topic><topic>Myocardium - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Rabbits</topic><topic>Ribonucleosides - therapeutic use</topic><topic>Time Factors</topic><topic>Ventricular Fibrillation - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BURCKHARTT, B</creatorcontrib><creatorcontrib>XI-MING YANG</creatorcontrib><creatorcontrib>TSUCHIDA, A</creatorcontrib><creatorcontrib>MULLANE, K. M</creatorcontrib><creatorcontrib>DOWNEY, J. M</creatorcontrib><creatorcontrib>COHEN, M. V</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BURCKHARTT, B</au><au>XI-MING YANG</au><au>TSUCHIDA, A</au><au>MULLANE, K. M</au><au>DOWNEY, J. M</au><au>COHEN, M. V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits</atitle><jtitle>Cardiovascular research</jtitle><addtitle>Cardiovasc Res</addtitle><date>1995-05</date><risdate>1995</risdate><volume>29</volume><issue>5</issue><spage>653</spage><epage>657</epage><pages>653-657</pages><issn>0008-6363</issn><eissn>1755-3245</eissn><coden>CVREAU</coden><abstract>Ischaemic preconditioning protects myocardium from infarction if the reperfusion interval between the brief and prolonged ischaemic intervals is less than 1 h. In anaesthetised rabbits acadesine (5-amino-4-imidazolecarboxamide riboside, AICAR), an adenosine enhancer which increases tissue adenosine during ischaemia, prolongs the window of protection to 2 h. The aim of this study was to try to determine the maximum extension of this window of protection, using chronically instrumented, unsedated rabbits.
Rabbits were instrumented with a balloon occluder around a major branch of the left coronary artery for reversible coronary occlusion. Five to seven days after surgery all animals underwent a 30 min coronary occlusion. Animals were randomised to one of seven groups: (1) No additional treatment (control); (2) Ischaemic preconditioning with 5 min regional ischaemia followed by 10 min reperfusion before the 30 min coronary occlusion; (3) and (4) Ischaemic preconditioning followed by 2 or 4 h of reperfusion before the 30 min occlusion, respectively; (5) Treatment with acadesine (2.5 mg.kg-1.min-1 intravenously for 5 min and then 0.5 mg.kg-1.min-1 beginning 45 min before and continuing until 30 min after release of the 30 min occlusion) without ischaemic preconditioning; (6) and (7) Treatment with the higher dose of acadesine for 5 min beginning 35 min before the 5 min ischaemic period, and then the lower dose continuing until 30 min after release of the 30 min coronary occlusion in rabbits with 4 or 6 h reperfusion intervals, respectively.
Rabbits with ischaemic preconditioning with 10 min reperfusion preceding the 30 min coronary occlusion (group 2) had only 5.6(SEM 1.1)% infarction of the ischaemic zone. Ischaemic preconditioning followed by 2 h reperfusion (group 3) offered continued protection [18.2(2.2)% infarction] as compared to control animals [37.7(2.6)% infarction]. However, protection waned if ischaemic preconditioning was followed by 4 h reperfusion (group 4) [36.7(3.0)% infarction]. Additionally, treatment with acadesine alone did not modify infarct size (group 7) [39.5(4.0)%], but acadesine largely restored the protection of ischaemic preconditioning despite a 4 h reperfusion interval (group 5) [20.4(3.0)% infarction, P < 0.01 v control]. However, when reperfusion was extended to 6 h (group 6) acadesine could no longer restore protection [36.2(0.9)% infarction].
The protection afforded by a 5 min ischaemic preconditioning period lasts from 2 to 4 h in the awake, unsedated rabbit, and acadesine can extend the duration of this window of protection to at least 4 h but not to 6 h.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>7606753</pmid><doi>10.1016/0008-6363(96)88636-6</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-6363 |
ispartof | Cardiovascular research, 1995-05, Vol.29 (5), p.653-657 |
issn | 0008-6363 1755-3245 |
language | eng |
recordid | cdi_proquest_miscellaneous_77382984 |
source | MEDLINE; Oxford University Press Journals Digital Archive Legacy |
subjects | Adenosine - metabolism Aminoimidazole Carboxamide - analogs & derivatives Aminoimidazole Carboxamide - therapeutic use Animals Biological and medical sciences Cardiovascular system Disease Models, Animal Medical sciences Miscellaneous Myocardial Infarction - prevention & control Myocardial Ischemia - metabolism Myocardial Reperfusion Myocardium - metabolism Pharmacology. Drug treatments Rabbits Ribonucleosides - therapeutic use Time Factors Ventricular Fibrillation - prevention & control |
title | Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T17%3A27%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acadesine%20extends%20the%20window%20of%20protection%20afforded%20by%20ischaemic%20preconditioning%20in%20conscious%20rabbits&rft.jtitle=Cardiovascular%20research&rft.au=BURCKHARTT,%20B&rft.date=1995-05&rft.volume=29&rft.issue=5&rft.spage=653&rft.epage=657&rft.pages=653-657&rft.issn=0008-6363&rft.eissn=1755-3245&rft.coden=CVREAU&rft_id=info:doi/10.1016/0008-6363(96)88636-6&rft_dat=%3Cproquest_cross%3E77382984%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77382984&rft_id=info:pmid/7606753&rfr_iscdi=true |